跳至主要内容
临床试验/ISRCTN22305120
ISRCTN22305120已完成不适用

The role of platelet activation and inflammation in the adverse Cardiovascular outcomes of patients undergoing surgery for Critical Limb ISchaemia: a double-blind randomised controlled trial of clopidogrel

othian Health Board (LHB) (UK)0 个研究点目标入组 100 人开始时间: 2008年6月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients aged greater than 45 years, either sex
  • 2. Critical limb ischaemia, defined as the presence of rest pain or skin breakdown, and an ankle-brachial pressure index less than 0.2
  • 3. Scheduled for infra-inguinal bypass, endarterectomy or amputation under general anaesthesia

排除标准

  • 1. Women of child bearing potential
  • 2. Non-atherosclerotic vascular disease
  • 3. Sudden acute limb ischaemia requiring emergency surgery
  • 4. Supra-inguinal or aortic surgery
  • 5. History of acute coronary syndrome within three months
  • 6. History of peptic ulcer disease
  • 7. Previous or current intracranial haemorrhage
  • 8. Bleeding diathesis
  • 9. Uncontrolled hypertension or thrombocytopenia
  • 10. Planned epidural or spinal anaesthesia
  • 11. Hypersensitivity or allergy to thienopyridines
  • 12. Current warfarin or thienopyridine use

研究者

发起方
othian Health Board (LHB) (UK)

相似试验